172 related articles for article (PubMed ID: 2656353)
1. Seasonality of type 1 (insulin-dependent) diabetes mellitus: values of C-peptide, insulin antibodies and haemoglobin A1c show evidence of a more rapid loss of insulin secretion in epidemic patients.
Ludvigsson J; Afoke AO
Diabetologia; 1989 Feb; 32(2):84-91. PubMed ID: 2656353
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.
Wallensteen M; Dahlquist G; Persson B; Landin-Olsson M; Lernmark A; Sundkvist G; Thalme B
Diabetologia; 1988 Sep; 31(9):664-9. PubMed ID: 3069534
[TBL] [Abstract][Full Text] [Related]
3. Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes.
Knip M; Ilonen J; Mustonen A; Akerblom HK
Diabetologia; 1986 Jun; 29(6):347-51. PubMed ID: 3527834
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children.
Sochett EB; Daneman D; Clarson C; Ehrlich RM
Diabetologia; 1987 Jul; 30(7):453-9. PubMed ID: 3311859
[TBL] [Abstract][Full Text] [Related]
5. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
Samuelsson U; Ludvigsson J; Sundkvist G
Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effect of islet B-cell function in insulin-treated diabetes.
Gjessing HJ; Matzen LE; Iversen S; Faber OK; Frøland A
Scand J Clin Lab Invest; 1989 Jun; 49(4):337-43. PubMed ID: 2662383
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.
Couper JJ; Hudson I; Werther GA; Warne GL; Court JM; Harrison LC
Diabetes Res Clin Pract; 1991 Jan; 11(1):9-16. PubMed ID: 2019237
[TBL] [Abstract][Full Text] [Related]
8. Raised IgG and IgM in "epidemic" IDDM suggest that infections are responsible for the seasonality of type I diabetes.
Afoke A; Ludvigsson J; Hed J; Lindblom B
Diabetes Res; 1991 Jan; 16(1):11-7. PubMed ID: 1818792
[TBL] [Abstract][Full Text] [Related]
9. [The role of insulin secretion and insulin resistance in the clinical course of newly diagnosed diabetes mellitus in children].
Szadkowska A; Pietrzak I; Markuszewski L; Bodalski J
Med Wieku Rozwoj; 2005; 9(2):223-34. PubMed ID: 16085963
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
Gjessing HJ; Matzen LE; Faber OK; Frøland A
Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
[TBL] [Abstract][Full Text] [Related]
11. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
Chaillous L; Lefèvre H; Thivolet C; Boitard C; Lahlou N; Atlan-Gepner C; Bouhanick B; Mogenet A; Nicolino M; Carel JC; Lecomte P; Maréchaud R; Bougnères P; Charbonnel B; Saï P
Lancet; 2000 Aug; 356(9229):545-9. PubMed ID: 10950231
[TBL] [Abstract][Full Text] [Related]
12. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
[TBL] [Abstract][Full Text] [Related]
13. Better HbA1c during the first years after diagnosis of type 1 diabetes is associated with residual C peptide 10 years later.
Grönberg A; Espes D; Carlsson PO
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32107263
[TBL] [Abstract][Full Text] [Related]
14. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
[TBL] [Abstract][Full Text] [Related]
15. Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.
Gjessing HJ; Matzen LE; Faber OK; Frøland A
Diabetologia; 1989 May; 32(5):305-11. PubMed ID: 2666217
[TBL] [Abstract][Full Text] [Related]
16. HLA-types, C-peptide and insulin antibodies in juvenile diabetes.
Ludvigsson J; Säfwenberg J; Heding LG
Diabetologia; 1977 Jan; 13(1):13-7. PubMed ID: 838199
[TBL] [Abstract][Full Text] [Related]
17. Glucose profiles in children two years after the onset of type 1 diabetes.
Simell T; Simell O; Lammi EM; Kaprio EA; Hakulinen A; Hakalax J; Mäenpää J
Diabet Med; 1993 Jul; 10(6):524-9. PubMed ID: 8365087
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin profiles in consecutive children 2 years after the diagnosis of IDDM.
Simell T; Mäenpää J; Kaprio EA; Hakulinen A; Hakalax J; Sipilä I; Akerblom HK; Simell O
Diabetologia; 1995 Jan; 38(1):97-105. PubMed ID: 7744234
[TBL] [Abstract][Full Text] [Related]
19. Natural course of remission in IDDM during 1st yr after diagnosis.
Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
[TBL] [Abstract][Full Text] [Related]
20. Indications for a more aggressive disease process in newly diagnosed insulin-dependent diabetic children in northern than in southern Europe.
Samuelsson U; Ludvigsson J; Bottazzo GF; Shattock M; Adolfsson S; Becker D; Cacciari E; Chiarelli F; Chiumello G; Deschamps I
Acta Diabetol; 1994 Jun; 31(2):107-15. PubMed ID: 7949221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
